Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction

研究多物质滥用和成瘾模式的系统遗传学

基本信息

  • 批准号:
    10555228
  • 负责人:
  • 金额:
    $ 64.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-15 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

Abstract. Polysubstance Substance Use (PSU) is common among individuals meeting diagnosis for any substance use disorder (SUD) and is defined as the use of two or more addictive drugs. These drug combinations are associated with increased short- and long-term mental and physical health concerns. Due to the high degree of variability in PSU patterns, limited data are available regarding the molecular mechanisms underlying PSU vulnerability. The overall goal of this project is to use novel approaches based on genome-wide data to dissect the fundamental biology of polysubstance abuse and addiction. In the R21 phase of this proposal, we will conduct heritability and high-resolution cross-phenotype polygenic risk score (PRS) analyses of probabilities of PSU classes in three moderately-large study populations characterized by a high degree of PSU, our Yale-Penn cohort, the SAGE (Study of Addiction: Genetics and Environment) cohort, and the ICGHD (International Consortium on the Genetics of Heroin Dependence) cohort. The PSU pattern will be identified applying latent class analysis (LCA) and a multinomial logistic regression procedure to substance use data available from the SSADDA (Semi-structured Assessment for Drug Dependence and Alcoholism; Yale-Penn Cohort), the SSAGA (Semi-Structured Assessment for the Genetics of Alcoholism; SAGE cohort), and the SSAGA-OZ (SSAGA – Australia; ICGHD cohort). We expect that the R21-Phase analyses will identify heritable PSU patterns and gene sets associated with them, providing the background necessary to investigate PSU in other molecular paradigms. In the R33 phase of the project, we will test the R21-phase results with respect to two different settings: 1) longitudinal PSU data; and 2) PSU-induced epigenetic changes. Re-contacting a sub-sample of the Yale-Penn cohort, we will be able to assess the trajectory of PSU patterns and the consequences of PSU and to test whether the genetic factors associated with the initial PSU status predict the PSU trajectories and consequences. Similarly, we will also test whether heritable PSU correlates with epigenetic changes and whether these mediate health outcomes. The expected results of the R33 phase will provide multiple findings related to the biology of PSU that can improve clinical practice, deliver new therapeutic targets, and open new directions in molecular investigations of PSU.
抽象。多物质物质使用(PSU)是常见的个人会议 任何物质使用障碍(SUD)的诊断,并定义为使用两个或两个以上 上瘾的毒品这些药物组合与增加的短期和长期 精神和身体健康问题。由于PSU模式的高度可变性, 关于PSU脆弱性的分子机制的数据有限。 该项目的总体目标是使用基于全基因组数据的新方法, 剖析多种物质滥用和成瘾的基本生物学。在R21阶段, 建议,我们将进行遗传力和高分辨率交叉表型多基因风险评分 (PRS)三个中等规模研究人群中PSU类别的概率分析 以高度的PSU为特征,我们的耶鲁-宾夕法尼亚大学队列,SAGE(成瘾研究: 遗传学和环境)队列,以及ICGHD(国际遗传学联盟, 海洛因依赖)队列。PSU模式将通过潜在类别分析进行识别 (LCA)和多项逻辑回归程序的物质使用数据可从 药物依赖和酒精中毒半结构评估 酒精中毒遗传学半结构评估(SSAGA) 组群)和SSAGA-OZ(SSAGA -澳大利亚; ICGHD组群)。我们期望R21期分析将识别可遗传的PSU模式和与它们相关的基因集, 为研究PSU在其他分子模式中的作用提供了必要的背景。在 R33阶段的项目,我们将测试R21阶段的结果,就两个不同的 设置:1)纵向PSU数据;和2)PSU诱导的表观遗传变化。重新联系 亚样本的耶鲁-宾夕法尼亚大学队列,我们将能够评估的轨迹PSU模式 和PSU的后果,并测试是否与初始的遗传因素有关, PSU状态预测PSU轨迹和后果。同样,我们也将测试 遗传性PSU与表观遗传变化以及这些变化是否介导健康结果相关。 R33阶段的预期结果将提供与以下生物学相关的多项发现: PSU可以改善临床实践,提供新的治疗目标,并开辟新的方向 PSU的分子研究。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of microbes in the pathogenesis of neuropsychiatric disorders.
  • DOI:
    10.1016/j.yfrne.2021.100917
  • 发表时间:
    2021-07
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Goswami A;Wendt FR;Pathak GA;Tylee DS;De Angelis F;De Lillo A;Polimanti R
  • 通讯作者:
    Polimanti R
ACE2 Netlas: In silico Functional Characterization and Drug-Gene Interactions of ACE2 Gene Network to Understand Its Potential Involvement in COVID-19 Susceptibility.
  • DOI:
    10.3389/fgene.2021.698033
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Pathak GA;Wendt FR;Goswami A;Koller D;De Angelis F;COVID-19 Host Genetics Initiative;Polimanti R
  • 通讯作者:
    Polimanti R
Drinking and smoking polygenic risk is associated with childhood and early-adulthood psychiatric and behavioral traits independently of substance use and psychiatric genetic risk.
  • DOI:
    10.1038/s41398-021-01713-z
  • 发表时间:
    2021-11-13
  • 期刊:
  • 影响因子:
    6.8
  • 作者:
    De Angelis F;Wendt FR;Pathak GA;Tylee DS;Goswami A;Gelernter J;Polimanti R
  • 通讯作者:
    Polimanti R
Evaluating a novel 8-factor dimensional model of PTSD in U.S. military veterans: Results from the National Health and Resilience in Veterans Study.
评估美国退伍军人创伤后应激障碍 (PTSD) 的新型 8 因素维度模型:退伍军人国家健康和复原力研究的结果。
  • DOI:
    10.1016/j.jad.2023.11.041
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    6.6
  • 作者:
    Stiltner,Brendan;Fischer,IanC;Duek,Or;Polimanti,Renato;Harpaz-Rotem,Ilan;Pietrzak,RobertH
  • 通讯作者:
    Pietrzak,RobertH
Characterizing the effect of background selection on the polygenicity of brain-related traits.
描述背景选择对大脑相关性状多基因性的影响。
  • DOI:
    10.1016/j.ygeno.2020.11.032
  • 发表时间:
    2021-01
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Wendt FR;Pathak GA;Overstreet C;Tylee DS;Gelernter J;Atkinson EG;Polimanti R
  • 通讯作者:
    Polimanti R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RENATO POLIMANTI其他文献

RENATO POLIMANTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RENATO POLIMANTI', 18)}}的其他基金

Leveraging genomic data to dissect the association of internalizing disorders with the risk, onset, and vulnerability of COVID-19
利用基因组数据剖析内化障碍与 COVID-19 风险、发病和脆弱性的关联
  • 批准号:
    10612299
  • 财政年份:
    2022
  • 资助金额:
    $ 64.53万
  • 项目类别:
Genome-wide Investigation of the Interplay Between Age-Related Hearing Loss and Smoking Behaviors
年龄相关性听力损失与吸烟行为之间相互作用的全基因组调查
  • 批准号:
    9980844
  • 财政年份:
    2019
  • 资助金额:
    $ 64.53万
  • 项目类别:
Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction
研究多物质滥用和成瘾模式的系统遗传学
  • 批准号:
    10368162
  • 财政年份:
    2019
  • 资助金额:
    $ 64.53万
  • 项目类别:
Genome-wide Investigation of the Interplay Between Age-Related Hearing Loss and Smoking Behaviors
年龄相关性听力损失与吸烟行为之间相互作用的全基因组调查
  • 批准号:
    9813620
  • 财政年份:
    2019
  • 资助金额:
    $ 64.53万
  • 项目类别:
Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction
研究多物质滥用和成瘾模式的系统遗传学
  • 批准号:
    10334662
  • 财政年份:
    2019
  • 资助金额:
    $ 64.53万
  • 项目类别:
Genome-wide Investigation of the Interplay Between Age-Related Hearing Loss and Smoking Behaviors
年龄相关性听力损失与吸烟行为之间相互作用的全基因组调查
  • 批准号:
    10237374
  • 财政年份:
    2019
  • 资助金额:
    $ 64.53万
  • 项目类别:

相似海外基金

Development and evaluation of a smartphone application to promote the use of alcoholism Self-help groups
开发和评估智能手机应用程序以促进酗酒自助团体的使用
  • 批准号:
    23K02994
  • 财政年份:
    2023
  • 资助金额:
    $ 64.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE, AFFECT AND PAIN MODELS OF ALCOHOLISM
酗酒的依赖性、影响和疼痛模型的临床前药物筛选
  • 批准号:
    10953233
  • 财政年份:
    2023
  • 资助金额:
    $ 64.53万
  • 项目类别:
Fragment-based Discovery of COMT Inhibitors as a Novel Pharmacotherapy for Alcoholism
基于片段的 COMT 抑制剂的发现作为酒精中毒的新型药物疗法
  • 批准号:
    10667129
  • 财政年份:
    2023
  • 资助金额:
    $ 64.53万
  • 项目类别:
Voicing the Experience of Adolescents in Francophone Narratives of Family Alcoholism
在家庭酗酒的法语叙述中表达青少年的经历
  • 批准号:
    2778431
  • 财政年份:
    2022
  • 资助金额:
    $ 64.53万
  • 项目类别:
    Studentship
ALCOHOLISM SOLUTIONS: SYNTHESIZING INFORMATION TO SUPPORT TREATMENTS (ASSIST 2.0)
酗酒解决方案:综合信息以支持治疗(ASSIST 2.0)
  • 批准号:
    10717436
  • 财政年份:
    2022
  • 资助金额:
    $ 64.53万
  • 项目类别:
Alcoholism Solutions: Synthesizing Information to Support Treatments (ASSIST 2.0)
酗酒解决方案:综合信息支持治疗 (ASSIST 2.0)
  • 批准号:
    10716165
  • 财政年份:
    2022
  • 资助金额:
    $ 64.53万
  • 项目类别:
Miserable One Half and Mad the Other: A Graphic History of Alcoholism at The Salutation Pub
一半悲惨,另一半疯狂:致敬酒吧酗酒的图解史
  • 批准号:
    2623065
  • 财政年份:
    2021
  • 资助金额:
    $ 64.53万
  • 项目类别:
    Studentship
Investigating the longitudinal relationship between alcohol use, neurophysiological functioning, and Alzheimer disease biomarkers in the Collaborative Study on the Genetics of Alcoholism
在酒精中毒遗传学合作研究中调查饮酒、神经生理功能和阿尔茨海默病生物标志物之间的纵向关系
  • 批准号:
    10660983
  • 财政年份:
    2020
  • 资助金额:
    $ 64.53万
  • 项目类别:
Neuroimaging multiple memory processes, glucocorticoids and alcoholism risk
神经影像学多重记忆过程、糖皮质激素和酗酒风险
  • 批准号:
    9977375
  • 财政年份:
    2020
  • 资助金额:
    $ 64.53万
  • 项目类别:
Multimodal Imaging of Cognitive Control in Individuals with a Family History of Alcoholism
有酗酒家族史的个体认知控制的多模态成像
  • 批准号:
    10228610
  • 财政年份:
    2020
  • 资助金额:
    $ 64.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了